Open the mobile version, with barcode scanning
Class II Ongoing

Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA.

Why: Subpotent Drug

Company
Major Pharmaceuticals
Dublin, OH, United States
Reported
Jul 29, 2026
Recall started
Jul 13, 2026
Where sold
Nationwide in the USA.
Amount
N/A
Full product description
Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6951-61
Lots / codes affected
Lot# N02172, exp 07/2026; N02296, N02288, Exp. Date 12/2026

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.